FTM
First Turn Management Portfolio holdings
AUM
$536M
This Quarter Return
+21.43%
1 Year Return
+36.36%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$668M
AUM Growth
+$668M
(-4%)
Cap. Flow
-$44.6M
Cap. Flow
% of AUM
-6.67%
Top 10 Holdings %
Top 10 Hldgs %
42.06%
Holding
40
New
9
Increased
10
Reduced
11
Closed
6
Top Buys
| 1 |
Apogee Therapeutics
APGE
|
$25.2M |
| 2 |
Spyre Therapeutics
SYRE
|
$17.6M |
| 3 |
Oric Pharmaceuticals
ORIC
|
$15.1M |
| 4 |
KalVista Pharmaceuticals
KALV
|
$14M |
| 5 |
Alphatec Holdings
ATEC
|
$13.7M |
Top Sells
| 1 |
CBAY
Cymabay Therapeutics
CBAY
|
$35.4M |
| 2 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$27.7M |
| 3 |
Cytokinetics
CYTK
|
$26.4M |
| 4 |
Insulet
PODD
|
$25M |
| 5 |
Krystal Biotech
KRYS
|
$19.8M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SWAV
1
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $31.9M | 4.78% |
98,111
+40,627
| +71% | +$13.2M |
|
2
argenx
ARGX
$43.6B
| $31.5M | 4.71% |
79,978
-3,425
| -4% | -$1.35M |
|
|
3
Cytokinetics
CYTK
$4.23B
| $30.2M | 4.51% |
430,349
-377,095
| -47% | -$26.4M |
|
4
Xenon Pharmaceuticals
XENE
$2.98B
| $29.3M | 4.38% |
680,389
| – | – |
|
5
Sarepta Therapeutics
SRPT
$1.78B
| $28.7M | 4.29% |
221,748
+17,866
| +9% | +$2.31M |
|
6
Axsome Therapeutics
AXSM
$6.05B
| $27.3M | 4.08% |
342,173
+46,745
| +16% | +$3.73M |
|
7
DexCom
DXCM
$29.5B
| $26.8M | 4% |
192,932
| – | – |
|
8
Immunocore
IMCR
$1.62B
| $25.7M | 3.84% |
394,674
+51,595
| +15% | +$3.35M |
|
|
9
Apogee Therapeutics
APGE
$2.17B
| $25.2M | 3.78% |
+379,803
| New | +$25.2M |
|
10
Vertex Pharmaceuticals
VRTX
$100B
| $24.6M | 3.68% |
58,832
-22,851
| -28% | -$9.55M |
|
11
Mirum Pharmaceuticals
MIRM
$3.71B
| $24.1M | 3.6% |
958,654
+122,352
| +15% | +$3.07M |
|
12
Biohaven
BHVN
$1.63B
| $23.6M | 3.54% |
432,342
-44,972
| -9% | -$2.46M |
|
|
13
Krystal Biotech
KRYS
$4.27B
| $23.3M | 3.48% |
130,850
-111,335
| -46% | -$19.8M |
|
14
Ascendis Pharma
ASND
$11.8B
| $22.9M | 3.43% |
151,587
| – | – |
|
15
Transmedics
TMDX
$3.92B
| $22M | 3.29% |
297,377
-25,808
| -8% | -$1.91M |
|
16
Day One Biopharmaceuticals
DAWN
$769M
| $21.8M | 3.26% |
1,318,207
-382,742
| -23% | -$6.32M |
|
17
Nuvalent
NUVL
$5.52B
| $20M | 2.99% |
265,897
+10,000
| +4% | +$751K |
|
18
Ionis Pharmaceuticals
IONS
$6.79B
| $18.3M | 2.73% |
421,487
+64,808
| +18% | +$2.81M |
|
19
Vaxcyte
PCVX
$4B
| $17.8M | 2.66% |
260,281
-97,247
| -27% | -$6.64M |
|
|
20
Spyre Therapeutics
SYRE
$996M
| $17.6M | 2.64% |
+464,435
| New | +$17.6M |
|
21
IDEAYA Biosciences
IDYA
$2.15B
| $17.5M | 2.61% |
397,782
+15,400
| +4% | +$676K |
|
22
Immunovant
IMVT
$2.56B
| $16.6M | 2.48% |
512,893
| – | – |
|
23
Disc Medicine
IRON
$2.07B
| $15.7M | 2.35% |
252,673
+95,399
| +61% | +$5.94M |
|
|
VRNA
24
Verona Pharma
VRNA
$9.16B
| $15.7M | 2.34% |
973,130
-233,161
| -19% | -$3.75M |
|
|
25
Oric Pharmaceuticals
ORIC
$994M
| $15.1M | 2.26% |
+1,097,571
| New | +$15.1M |
|